Post-ischaemic neovascularization and inflammation

Cardiovascular Research

Volumn 78, Issue 2, 2008, Pages 242-249

  Silvestre, Jean Sebastien ^a   Mallat, Ziad ^a   Tedgui, Alain ^a   Lévy, Bernard I ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Angiogenesis; Arteriogenesis; Inflammation; Ischaemia

Indexed keywords

CD47 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 16; INTERLEUKIN 18; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BNIP3; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANGIOGENESIS; ANTIGEN EXPRESSION; APOPTOSIS; ATHEROGENESIS; CELL PROLIFERATION; CORNEA NEOVASCULARIZATION; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC TRANSCRIPTION; HEART INFARCTION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; ISCHEMIA; LEUKOCYTE; MACROPHAGE; MECHANICAL STRESS; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVIEW; STEM CELL; THROMBOCYTE FUNCTION; TISSUE REPAIR; VASCULAR DISEASE;

ANGIOGENIC PROTEINS; ANIMALS; CELL HYPOXIA; COLLATERAL CIRCULATION; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; STEM CELLS; STRESS, MECHANICAL; WOUND HEALING;

EID: 42349091128     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn027     Document Type: Review

References (92)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660.
2. Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006;10:45-55.
3. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002;13:29-37.
4. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
5. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003;112:645-657.
6. Makino Y, Nakamura H, Ikeda E, Ohnuma K, Yamauchi K, Yabe Y et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol 2003;171:6534-6540.
7. Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci USA 2004;101:10440- 10445.
8. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999;94:1561-1567.
9. McMahon S, Charbonneau M, Grandmont S, Richard DE, Dubois CM. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 2006;281:24171-24181.
10. Murdoch C, Muthana M, Lewis CE. Hypoxia regulates macrophage functions in inflammation. J Immunol 2005;175:6257-6263.
11. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 2003;278:8508-8515.
12. Eitenmuller I, Volger O, Kluge A, Troidl K, Barancik M, Cai WJ et al. The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res 2006;99:656-662.
13. Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol 2004;24:1664-1668.
14. Shyy JY, Li YS, Lin MC, Chen W, Yuan S, Usami S et al. Multiple cis-elements mediate shear stress-induced gene expression. J Biomech 1995;28:1451-1457.
15. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997;80:829-837.
16. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 2004;95:449-458.
17. Morimoto H, Takahashi M, Izawa A, Ise H, Hongo M, Kolattukudy PE et al. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006;99:891-899.
18. Hoefer IE, van Royen N, Rectenwald JE, Deindl E, Hua J, Jost M et al. Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms. Circ Res 2004;94:1179-1185.
19. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T et al. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 2005;96:881- 889.
20. Tang G, Charo DN, Wang R, Charo IF, Messina L. CCR2-/- knockout mice revascularize normally in response to severe hindlimb ischemia. J Vasc Surg 2004;40:786-795.
21. Contreras-Shannon V, Ochoa O, Reyes-Reyna SM, Sun D, Michalek JE, Kuziel WA et al. Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/- mice following ischemic injury. Am J Physiol Cell Physiol 2007;292:C953-C967.
22. Waeckel L, Mallat Z, Potteaux S, Combadiere C, Clergue M, Duriez M et al. Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res 2005;96:576-582.
23. Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS et al. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischemia. Cardiovasc Res 2007; doi:10.1093/cvr/cvm067.
24. Ishida Y, Gao JL, Murphy PM. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008;180:569-579.
25. Egami K, Murohara T, Aoki M, Matsuishi T. Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin. J Leukoc Biol 2006;79:971-976.
26. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 1997;81:187-195.
27. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
28. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 2004;104:2084-2086.
29. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004;94:230-238.
30. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-262.
31. Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001;193:1005-1014.
32. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781-2786.
33. Aicher A, Rentsch M, Sasaki K, Ellwart JW, Fandrich F, Siebert R et al. Nonbone marrow-derived circulating progenitor cells contribute to post-natal neovascularization following tissue ischemia. Circ Res 2007;100:581-589.
34. You D, Waeckel L, Ebrahimian TG, Blanc-Brude O, Foubert P, Barateau V et al. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 2006;114:328-338.
35. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005;39:733-742.
36. Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-1169.
37. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006;12:557-567.
38. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006;124:175-189.
39. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004;24:288-293.
40. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-2516.
41. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002;283:H2411- H2419.
42. Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A et al. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 2003;108:205-210.
43. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 1999;99:3188-3198.
44. Stabile E, Kinnaird T, la Sala A, Hanson SK, Watkins C, Campia U et al. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation 2006;113:118-124.
45. van Weel V, Toes RE, Seghers L, Deckers MM, de Vries MR, Eilers PH et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol 2007;27:2310-2318.
46. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002;106:2019-2025.
47. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003;108:1912-1916.
48. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 2003;108:2034- 2040.
49. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004;287:R1014-R1030.
50. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-189.
51. Bayraktutan U, Blayney L, Shah AM. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. Arterioscler Thromb Vasc Biol 2000;20:1903- 1911.
52. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T et al. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 1999;64:249- 258.
53. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res 1997;81:24-33.
54. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M et al. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2002;91:1160-1167.
55. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 2005;111:2347-2355.
56. Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L et al. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 2006;169:719-728.
57. Duilio C, Ambrosio G, Kuppusamy P, DiPaula A, Becker LC, Zweier JL. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 2001;280:H2649-H2657.
58. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 1996;2:35-40.
59. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest 1981;68:1394-1403.
60. May AE, Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008.
61. Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006;10:355-362.
62. De Paula EV, Nascimento MC, Ramos CD, Ozelo MC, Machado TF, Guillaumon AT et al. Early in vivo anticoagulation inhibits the angiogenic response following hindlimb ischemia in a rodent model. Thromb Haemost 2006;96:68-72.
63. Caunt M, Hu L, Tang T, Brooks PC, Ibrahim S, Karpatkin S. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res 2006;66:4125-4132.
64. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006;203:1221-1233.
65. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006;98:e2-e10.
66. Smadja DM, Bieche I, Uzan G, Bompais H, Muller L, Boisson-Vidal C et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 2005;25:2321-2327.
67. Sunderkotter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991;51:195-216.
68. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005;111:2935-2942.
69. van Hinsbergh VW, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 2006;26:716-728.
70. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005;169:681-691.
71. Silvestre JS, Mallat Z, Duriez M, Tamarat R, Bureau MF, Scherman D et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2000;87:448-452.
72. Silvestre JS, Mallat Z, Tamarat R, Duriez M, Tedgui A, Levy BI. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res 2001;89:259-264.
73. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999;5:1135-1142.
74. Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res 2004;94:262-268.
75. Li J, Post M, Volk R, Gao Y, Li M, Metais C et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000;6:49-55.
76. Gao Y, Lecker S, Post MJ, Hietaranta AJ, Li J, Volk R et al. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. J Clin Invest 2000;106:439-448.
77. Fujii T, Yonemitsu Y, Onimaru M, Tanii M, Nakano T, Egashira K et al. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol 2006;26:2483-2489.
78. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002;8:831-840.
79. Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, deGasparo M et al. Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb. Hypertension 2002;39:830-835.
80. Tamarat R, Silvestre JS, Durie M, Levy BI. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 2002;82:747-756.
81. Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M et al. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2002;90:1072-1079.
82. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002;109:603-611.
83. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598-1603.
84. Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, Lecomte-Raclet L, Corbaz A, Clergue M et al. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ Res 2002;91:441-448.
85. Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, Chang AE et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998;101:1441-1452.
86. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-1553.
87. Kopp HG, Hooper AT, Broekman MJ, Avecilla ST, Petit I, Luo M et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. J Clin Invest 2006;116:3277-3291.
88. Isenberg JS, Romeo MJ, Abu-Asab M, Tsokos M, Oldenborg A, Pappan L et al. Increasing survival of ischemic tissue by targeting CD47. Circ Res 2007;100:712-720.
89. Lamy L, Foussat A, Brown EJ, Bornstein P, Ticchioni M, Bernard A. Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 2007;178:5930-5939.
90. van Royen N, Hoefer I, Bottinger M, Hua J, Grundmann S, Voskuil M et al. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ Res 2003;92:218-225.
91. Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M et al. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 2003;108:2839-2842.
92. Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001;89:E41-E45.